Browse > Article
http://dx.doi.org/10.3344/kjp.2022.35.4.468

Post-COVID-19 pain syndrome: a descriptive study in Turkish population  

Topal, Ilknur (Department of Physical Medicine and Rehabilitation, International School of Medicine, Istanbul Medipol University)
Ozcelik, Necdet (Department of Ear Nose Throat Diseases, International School of Medicine, Istanbul Medipol University)
Atayoglu, Ali Timucin (Department of Family Medicine, International School of Medicine, Istanbul Medipol University)
Publication Information
The Korean Journal of Pain / v.35, no.4, 2022 , pp. 468-474 More about this Journal
Abstract
Background: The new type of corona virus has a wide range of symptoms. Some people who have COVID-19 can experience long-term effects from their infection, known as post-COVID conditions. The authors aimed to investigate prolonged musculoskeletal pain as a symptom of the post-COVID-19 condition. Methods: This is a descriptive study on the patients who were diagnosed with COVID-19 in a university hospital, between March 2020 and March 2021. Patient records and an extensive questionnaire were used to obtain relevant demographic and clinical characteristics, including hospitalization history, comorbidities, smoking history, duration of the pain, the area of pain, and the presence of accompanying neuropathic symptoms. Results: Of the diagnosed patients, 501 agreed to participate in the study. Among the participants, 318 had musculoskeletal pain during COVID-19 infection, and 69 of them reported prolonged pain symptoms as part of their a post-COVID condition which could not be attributed to any other cause. The mean duration of pain was 4.38 ± 1.73 months, and the mean pain level was 7.2 ± 4.3. Neuropathic pain symptoms such as burning sensation (n = 16, 23.2%), numbness (n = 15, 21.7%), tingling (n = 10, 14.5%), stinging (n = 4, 5.8%), freezing (n = 1, 1.4%) were accompanied in patients with prolonged musculoskeletal pain. Conclusions: Patients with COVID-19 may develop prolonged musculoskeletal pain. In some patients, neuropathic pain accompanies it. Awareness of prolonged post-COVID-19 pain is crucial for its early detection and management.
Keywords
Chronic Pain; Complications; COVID-19; Musculoskeletal Pain; Neuralgia; Post-Acute COVID-19 Syndrome; Post-Infectious Disorders; Survey and Questionnaires;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-42.   DOI
2 Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010; 24: 1209-17.   DOI
3 Yalcin HC, Sukumaran V, Al-Ruweidi MKAA, Shurbaji S. Do changes in ACE-2 expression affect SARS-CoV-2 virulence and related complications: a closer look into membranebound and soluble forms. Int J Mol Sci 2021; 22: 6703.   DOI
4 To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 2004; 203: 740-3.   DOI
5 Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol 2019; 33: 101415.   DOI
6 Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopatho-logical characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health 2020; 8: e000406. Erratum in: Fam Med Community Health 2020; 8: e000406corr1.   DOI
7 Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277: 2251-61.   DOI
8 Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med 2020; 288: 335-44.   DOI
9 Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep 2021; 6: e884.   DOI
10 Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol 2013; 14: 77-85.   DOI
11 Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and taste dysfunction in patients with CO-VID-19: a systematic review and meta-analysis. Mayo Clin Proc 2020; 95: 1621-31.   DOI
12 Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, et al. Olfactory dysfunction in coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis 2020; 7: ofaa199.   DOI
13 Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417-8.   DOI
14 Uygun O, Ertas M, Ekizoglu E, Bolay H, Ozge A, Kocasoy Orhan E, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 2020; 21: 121   DOI
15 Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COV-ID-19): a systematic review and meta-analysis. Front Neurol 2020; 11: 565.   DOI
16 Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91: 157-60.
17 Corsini Campioli C, Cano Cevallos E, Assi M, Patel R, Binnicker MJ, O'Horo JC. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19. J Clin Virol 2020; 130: 104577.   DOI
18 Aksan F, Nelson EA, Swedish KA. A COVID-19 patient with intense burning pain. J Neurovirol 2020; 26: 800-1.   DOI
19 Bolay H, Gul A, Baykan B. COVID-19 is a real headache! Headache 2020; 60: 1415-21.   DOI
20 National Institute for Health and Care Excellence (NICE); Royal College of General Practitioners; Healthcare Improvement Scotland, Scottish Intercollegiate Guidelines Network (SIGN). COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet]. London: National Institute for Health and Care Excellence; 2020. Available at: www.nice.org.uk/guidance/ng188.
21 Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-8.   DOI
22 Grichnik KP, Ferrante FM. The difference between acute and chronic pain. Mt Sinai J Med 1991; 58: 217-20.
23 Garg P, Arora U, Kumar A, Wig N. The "post-COVID" syndrome: how deep is the damage? J Med Virol 2021; 93: 673-4.   DOI
24 Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 2020; 24: 353.   DOI
25 Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci 2020; 41: 3039-56.   DOI
26 Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain 2015; 156: 1003-7.   DOI
27 Campbell WI, Lewis S. Visual analogue measurement of pain. Ulster Med J 1990; 59: 149-54.
28 Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020; 92: 577-83.   DOI